Two Sigma Investments’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.3M Sell
775,121
-343,996
-31% -$8.22M 0.01% 1036
2025
Q4
$29.9M Buy
1,119,117
+453,226
+68% +$10.8M 0.04% 543
2025
Q3
$14.2M Buy
665,891
+182,793
+38% +$4.32M 0.02% 787
2025
Q2
$10.4M Sell
483,098
-333,558
-41% -$6.2M 0.02% 806
2025
Q1
$13.6M Sell
816,656
-426,786
-34% -$7.75M 0.03% 645
2024
Q4
$22.8M Buy
1,243,442
+133,186
+12% +$2.15M 0.05% 439
2024
Q3
$17.1M Buy
1,110,256
+762,539
+219% +$12.7M 0.04% 550
2024
Q2
$5.65M Buy
347,717
+238,288
+218% +$3.85M 0.01% 954
2024
Q1
$2.02M Sell
109,429
-239,299
-69% -$5.93M 0.01% 1473
2023
Q4
$10.9M Buy
348,728
+278,628
+397% +$6.65M 0.03% 646
2023
Q3
$1.46M Sell
70,100
-296,688
-81% -$8.06M ﹤0.01% 1683
2023
Q2
$8.78M Buy
366,788
+260,588
+245% +$5.79M 0.02% 697
2023
Q1
$2M Buy
106,200
+95,063
+854% +$1.81M 0.01% 1381
2022
Q4
$177K Buy
+11,137
New +$174K ﹤0.01% 2417
2022
Q3
Sell
-58,800
Closed -$828K 2436
2022
Q2
$828K Sell
58,800
-181,671
-76% -$3.39M ﹤0.01% 1623
2022
Q1
$5.82M Buy
240,471
+214,371
+821% +$5.19M 0.02% 855
2021
Q4
$609K Buy
26,100
+10,400
+66% +$209K ﹤0.01% 3045
2021
Q3
$261K Buy
15,700
+1,900
+14% +$36.6K ﹤0.01% 3763
2021
Q2
$337K Buy
+13,800
New +$311K ﹤0.01% 3420
2020
Q3
Sell
-286,618
Closed -$13.9M 3023
2020
Q2
$13.9M Buy
+286,618
New +$13.8M 0.08% 301
2020
Q1
Sell
-71,480
Closed -$3.06M 2998
2019
Q4
$3.06M Sell
71,480
-138,016
-66% -$6M 0.01% 1268
2019
Q3
$7.54M Buy
209,496
+10,873
+5% +$330K 0.03% 672
2019
Q2
$5.31M Buy
+198,623
New +$5.07M 0.02% 859
2017
Q1
Sell
-49,639
Closed -$1.43M 2837
2016
Q4
$1.43M Buy
+49,639
New +$1.31M 0.01% 1744

Other funds holding ACAD